| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 21, 2010
MINNEAPOLIS, Jun 21, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT) today announced the launch of KYPHON ActivOs 10 Bone Cement with Hydroxyapatite, a polymethylmethacrylate (PMMA) bone cement...
-
Jun 18, 2010Data from FAST-PVI Study Presented at Cardiostim 2010
MINNEAPOLIS, & NICE, France, Jun 18, 2010 (BUSINESS WIRE) --Data from the FAST-PVI study, supported by Medtronic, Inc. (NYSE: MDT), shows lab time using anatomically-designed ablation catheters...
-
Jun 17, 2010New Data Released at Cardiostim 2010 Shows Benefits of Advanced Shock Reduction Technologies
MINNEAPOLIS & NICE, France, Jun 17, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT) today announced European launch of the Protecta(TM)portfolio of implantable cardioverter-defibrillators (ICDs)...
-
Jun 17, 2010
MINNEAPOLIS, Jun 17, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Wells Fargo Securities 2010...
-
Jun 10, 2010
MINNEAPOLIS, Jun 10, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 31st Annual Healthcare...
-
Jun 10, 2010
MINNEAPOLIS, Jun 10, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the William Blair Growth Stock...
-
Jun 7, 2010iPro(TM)2 Professional CGM Provides Simple Way to Reveal Insights Into Glucose Control Not Possible With Standard Glucose Assessment Methods
MINNEAPOLIS, Jun 07, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE:MDT) announced today the launch of iPro(TM)2 Professional CGM, a continuous glucose monitoring (CGM) system used by physicians to...
-
Jun 2, 2010
MINNEAPOLIS, Jun 02, 2010 (BUSINESS WIRE) --In the largest, randomized, controlled study of deep brain stimulation (DBS) for Parkinson's disease, Medtronic DBS Therapy was shown to improve motor...
-
May 30, 2010Clinical Trial of Surgical Tissue Ablation Includes Two U.S. IDE Studies
MINNEAPOLIS, May 03, 2010 (BUSINESS WIRE) --Medtronic, Inc. (NYSE: MDT), today announced completion of patient enrollment in the first of two studies in the company's CURE-AF (Concomitant...
-
May 26, 2010Medtronic CoreValve(R) System Shows Long-Term Efficacy and Durability in Pivotal Trial
PARIS, May 26, 2010 (BUSINESS WIRE) --New clinical data presented today at EuroPCR demonstrate positive long-term performance and durability for the CoreValve transcatheter aortic valve...